FDA/EMA 'cluster' to aid info exchange on pharmacovigilance
This article was originally published in Scrip
Executive Summary
The FDA and the Europeans Medicines Agency (EMA) on 19 February said they have established a so-called "cluster" to exchange information via videoconference about pharmacovigilance topics.